Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.50 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.50 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | KDM5C | P41229 | 3/20 | 0.44 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.44 |
| ▸ | KDM6B | O15054 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27438605 | 1.00 | ACE (0.52) | ACEEGLN1LMNAALKBH5SUCNR1 | |
| SCHEMBL9618343 | 0.88 | HIF1A (0.41) | ACEEGLN1LMNAALKBH5SUCNR1 | |
| SCHEMBL4078931 | 0.87 | FNTA (0.53) | ACEEGLN1LMNAALKBH5SUCNR1 | |
| SCHEMBL4079596 | 0.85 | MAPT (0.56) | LMNACYP2C19FNTAFNTBTSHR | |
| SCHEMBL1470378 | 0.85 | LMNA (0.60) | ACEEGLN1LMNAALKBH5SUCNR1 | |
| SCHEMBL59553 | 0.85 | — | — | |
| Succinic Acid SCHEMBL5541307 | 0.85 | LMNA (0.60) | ACEEGLN1LMNAALKBH5SUCNR1 | |
| SCHEMBL31585729 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL31658236 | 0.82 | LMNA (0.56) | ACEEGLN1LMNAALKBH5SUCNR1 | |
| Hydrochloric Acid SCHEMBL8905629 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008089485-A2 | CARBOXYETHYLPYRROLE COMPOUNDS AND METHODS OF THEIR PRODUCTION | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-07-24 | — | — | WO | claimed |
| WO-2008089487-A2 | CARBOXYETHYLPYRROLE COMPOUNDS AND METHODS OF THEIR PRODUCTION | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-07-24 | — | — | WO | claimed |
| EP-4110345-A1 | PRODRUGS OF NEUROACTIVE STEROIDS | Brii Biosciences, Inc. (US) | 2023-01-04 | — | — | EP | disclosed |
| CN-115461055-A | Prodrugs of neuroactive steroids | 腾盛博药生物科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| US-20170176470-A1 | DETECTION OF CARBOXYALKYLPYRROLE OR PENTYLPYRROLE ETHANOLAMINE PHOSPHOLIPIDS | UNIV CASE WESTERN RESERVE (US) | 2017-06-22 | — | — | US | disclosed |
| US-20160108114-A1 | Compositions And Methods For Macular Degeneration | CLEVELAND CLINIC FOUNDATION (US) | 2016-04-21 | — | — | US | disclosed |
| EP-2049156-B1 | COMPOSITIONS AND METHODS FOR MACULAR DEGENERATION | CLEVELAND CLINIC FOUNDATION (US) | 2013-09-25 | — | — | EP | disclosed |
| US-20120230996-A1 | Compositions And Methods For Macular Degeneration | The Cleveland Clinic Foundation and Case Western Reserve University (US) | 2012-09-13 | — | — | US | disclosed |
| US-8137991-B2 | Methods of reducing angiogenesis of age-related macular degeneration (AMD) or choroidal neovascularization by an anti-carboxyetheylpyrrole (CFP) antibody | THE CLEVELAND CLINIC FOUNDATION (US) | 2012-03-20 | — | — | US | disclosed |
| EP-2233504-A1 | AN ERYTHROPOIETIN MIMETIC PEPTIDE DERIVATIVES AND ITS PHARMACEUTICAL SALT, THE PREPARATION AND USES THEREOF | Jiangsu Hansoh Pharmaceutical Co., Ltd. (CN) | 2010-09-29 | — | — | EP | disclosed |
| US-20100143380-A1 | COMPOSITIONS AND METHODS FOR MACULAR DEGENERATION | CLEVELAND CLINIC FOUNDATION, THE | 2010-06-10 | — | — | US | disclosed |
| WO-2008089485-A2 | CARBOXYETHYLPYRROLE COMPOUNDS AND METHODS OF THEIR PRODUCTION | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008089485-A2 | CARBOXYETHYLPYRROLE COMPOUNDS AND METHODS OF THEIR PRODUCTION | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008089487-A2 | CARBOXYETHYLPYRROLE COMPOUNDS AND METHODS OF THEIR PRODUCTION | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-07-24 | — | — | WO | disclosed |
| US-20080160505-A1 | DIAGNOSTIC METHODS FOR AGE RELATED MACULAR DEGENERATION | THE CLEVELAND CLINIC FOUNDATION | 2008-07-03 | — | — | US | disclosed |
| US-7341839-B2 | Diagnostic methods for age related macular degeneration | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-03-11 | — | — | US | disclosed |
| WO-2008013797-A2 | COMPOSITIONS AND METHODS FOR MACULAR DEGENERATION | THE CLEVELAND CLINIC FOUNDATION (US) | 2008-01-31 | — | — | WO | disclosed |
| US-20070072241-A1 | diagnosing age-related macular degeneration comprising determining the level of anti-2-( omega -carboxyethyl) pyrrole (CEP) antibodies in a bodily fluid obtained from the test subject | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-03-29 | — | — | US | disclosed |
| US-7172874-B2 | Diagnostic methods for age related macular degeneration | THE CLEVELAND CLINIC FOUNDATION (US) | 2007-02-06 | — | — | US | disclosed |
| US-20040265924-A1 | Diagnostic methods for age related macular degeneration | THE CLEVELAND CLINIC FOUNDATION | 2004-12-30 | — | — | US | disclosed |